• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

炎症性肠病与心血管事件发生率增加有关。

Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.

机构信息

Department of Medicine, University of Miami/Miller School of Medicine, Miami, FL, USA.

出版信息

Am J Gastroenterol. 2011 Apr;106(4):741-7. doi: 10.1038/ajg.2011.63. Epub 2011 Mar 8.

DOI:10.1038/ajg.2011.63
PMID:21386828
Abstract

OBJECTIVES

Patients with inflammatory bowel disease (IBD) present with several extraintestinal manifestations, including systemic inflammation and hypercoagulability. Limited studies have shown that patients with IBD may have a higher risk of developing atherosclerosis. The incidence of coronary artery disease (CAD) and the role of traditional CAD risk factors in IBD patients remain unclear. We sought to compare the rates of CAD events in patients with IBD with matched controls.

METHODS

We performed a longitudinal cohort study of patients with IBD compared with matched controls. The primary outcome was the development of CAD events. Traditional and nontraditional CAD risk factors were assessed. Cox proportional hazards model was used to assess the impact of each CAD risk factor on the outcomes.

RESULTS

A total of 356 IBD patients and 712 matched controls were followed for a median of 53 and 51 months, respectively. The unadjusted hazard ratio (HR) for developing CAD in the IBD group was 2.85 (95% confidence interval (CI) 1.82-4.46). IBD patients had significantly lower rates of selected traditional CAD risk factors (hypertension, diabetes, dyslipidemia, and obesity; P<0.01 for all). Adjusting for these factors, the HR for developing CAD between groups was 4.08 (95% CI 2.49-6.70). Among nontraditional risk factors, an elevated white blood cell (WBC) count was a risk factor for CAD development in the IBD group (HR 1.23; 95% CI 1.15-1.33).

CONCLUSIONS

An increased incidence of CAD events was noted in IBD patients despite having a lower burden of traditional risk factors. Additionally, these risk factors had a lower impact on CAD development in the IBD group. Further investigation into how nontraditional risk factors, including WBC count, and the effect of attenuating systemic inflammation in IBD patients change CAD risk is warranted.

摘要

目的

炎症性肠病(IBD)患者存在多种肠外表现,包括全身炎症和高凝状态。有限的研究表明,IBD 患者可能有更高的患动脉粥样硬化风险。冠心病(CAD)的发病率和传统 CAD 危险因素在 IBD 患者中的作用尚不清楚。我们旨在比较 IBD 患者和匹配对照者的 CAD 事件发生率。

方法

我们对 IBD 患者和匹配对照者进行了一项纵向队列研究。主要结局是 CAD 事件的发生。评估了传统和非传统 CAD 危险因素。使用 Cox 比例风险模型评估每个 CAD 危险因素对结局的影响。

结果

共纳入 356 例 IBD 患者和 712 例匹配对照者,中位随访时间分别为 53 个月和 51 个月。校正混杂因素后,IBD 组发生 CAD 的风险比(HR)为 2.85(95%可信区间 1.82-4.46)。IBD 患者的某些传统 CAD 危险因素(高血压、糖尿病、血脂异常和肥胖)的发生率显著降低(所有 P<0.01)。校正这些因素后,两组间发生 CAD 的 HR 为 4.08(95%可信区间 2.49-6.70)。在非传统危险因素中,白细胞(WBC)计数升高是 IBD 组 CAD 发生的危险因素(HR 1.23;95%可信区间 1.15-1.33)。

结论

尽管 IBD 患者的传统危险因素负担较低,但 CAD 事件的发生率仍较高。此外,这些危险因素对 IBD 组 CAD 发生的影响较小。进一步研究非传统危险因素(包括 WBC 计数)以及减轻 IBD 患者全身炎症对 CAD 风险的影响是有必要的。

相似文献

1
Inflammatory bowel disease is associated with an increased incidence of cardiovascular events.炎症性肠病与心血管事件发生率增加有关。
Am J Gastroenterol. 2011 Apr;106(4):741-7. doi: 10.1038/ajg.2011.63. Epub 2011 Mar 8.
2
Conventional risk factors and cardiovascular outcomes of patients with inflammatory bowel disease with confirmed coronary artery disease.炎症性肠病合并确诊冠心病患者的传统危险因素及心血管结局
Inflamm Bowel Dis. 2014 Sep;20(9):1593-601. doi: 10.1097/MIB.0000000000000109.
3
Increased risk of pneumonia among patients with inflammatory bowel disease.炎症性肠病患者肺炎风险增加。
Am J Gastroenterol. 2013 Feb;108(2):240-8. doi: 10.1038/ajg.2012.406. Epub 2013 Jan 8.
4
Inflammatory bowel disease and coronary artery disease.炎症性肠病与冠状动脉疾病。
Indian J Gastroenterol. 2009 Jan-Feb;28(1):28-30. doi: 10.1007/s12664-009-0006-3. Epub 2009 Jun 6.
5
Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts.开发电子病历表型算法以比较3个慢性病队列中冠状动脉疾病风险的方法。
PLoS One. 2015 Aug 24;10(8):e0136651. doi: 10.1371/journal.pone.0136651. eCollection 2015.
6
Coronary artery disease incidence, risk factors, awareness, and medication utilization in a 10-year cohort study.在一项为期 10 年的队列研究中,冠心病的发病率、危险因素、知晓率和药物利用情况。
BMC Cardiovasc Disord. 2024 Feb 12;24(1):101. doi: 10.1186/s12872-024-03769-3.
7
State of the art review: coronary artery disease in patients with inflammatory bowel disease: mechanisms, prevalence, and outcomes.综述:炎症性肠病患者的冠状动脉疾病:发病机制、患病率和结局。
Acta Cardiol. 2022 Jun;77(4):297-306. doi: 10.1080/00015385.2021.1940607. Epub 2021 Jul 13.
8
Hypoglycemia in Diabetes Mellitus as a Coronary Artery Disease Risk Factor in Patients at Elevated Vascular Risk.糖尿病患者低血糖作为血管风险升高患者的冠状动脉疾病危险因素
J Clin Endocrinol Metab. 2016 Feb;101(2):659-68. doi: 10.1210/jc.2015-3169. Epub 2015 Dec 16.
9
Risk of Cardiovascular Disease Associated with a Restless Legs Syndrome Diagnosis in a Retrospective Cohort Study from Kaiser Permanente Northern California.加利福尼亚州 Kaiser 永久医疗集团一项回顾性队列研究显示,不安腿综合征与心血管疾病风险相关。
Sleep. 2015 Jul 1;38(7):1009-15. doi: 10.5665/sleep.4800.
10
Persistent Reactive Thrombocytosis May Increase the Risk of Coronary Artery Disease Among Inflammatory Bowel Disease Patients.持续性反应性血小板增多症可能会增加炎症性肠病患者患冠状动脉疾病的风险。
Dig Dis Sci. 2015 Oct;60(10):3062-8. doi: 10.1007/s10620-015-3701-1. Epub 2015 May 14.

引用本文的文献

1
From Gut Inflammation to Cardiovascular Conflagration: Mapping IBD's Cardiometabolic Risks.从肠道炎症到心血管“战火”:梳理炎症性肠病的心血管代谢风险
Curr Atheroscler Rep. 2025 Sep 10;27(1):89. doi: 10.1007/s11883-025-01329-4.
2
Strategies for assessing and preventing cardiovascular disease risk in inflammatory bowel disease patients: A meta-analysis and meta-regression and bibliometric review.评估和预防炎症性肠病患者心血管疾病风险的策略:一项荟萃分析、元回归分析和文献计量学综述
PLoS One. 2025 Jul 28;20(7):e0327734. doi: 10.1371/journal.pone.0327734. eCollection 2025.
3
Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review.
炎症性肠病患者的心脏代谢疾病:一项循证综述。
World J Gastroenterol. 2025 Jun 28;31(24):107661. doi: 10.3748/wjg.v31.i24.107661.
4
Gut-Heart Axis: Microbiome Involvement in Restrictive Cardiomyopathies.肠-心轴:微生物群与限制型心肌病的关系
Biomedicines. 2025 Jan 9;13(1):144. doi: 10.3390/biomedicines13010144.
5
Cardiovascular events observed among patients in the etrasimod clinical programme: an integrated safety analysis of patients with moderately to severely active ulcerative colitis.在etrasimod临床项目患者中观察到的心血管事件:对中度至重度活动性溃疡性结肠炎患者的综合安全性分析。
BMJ Open Gastroenterol. 2025 Jan 8;12(1):e001516. doi: 10.1136/bmjgast-2024-001516.
6
Comparison of volumetric brain analysis in subjects with rheumatoid arthritis and ulcerative colitis.类风湿性关节炎和溃疡性结肠炎患者脑容量分析的比较。
Front Med (Lausanne). 2024 Nov 20;11:1468910. doi: 10.3389/fmed.2024.1468910. eCollection 2024.
7
Protective effects of long term antiplatelet and anticoagulant therapy in hospitalized patients with inflammatory bowel disease.长期抗血小板和抗凝治疗对炎症性肠病住院患者的保护作用。
World J Gastrointest Pharmacol Ther. 2024 Nov 5;15(6):95532. doi: 10.4292/wjgpt.v15.i6.95532.
8
Cardiovascular Risk in Patients with Inflammatory Bowel Diseases-The Role of Endothelial Dysfunction.炎症性肠病患者的心血管风险——内皮功能障碍的作用
Diagnostics (Basel). 2024 Aug 8;14(16):1722. doi: 10.3390/diagnostics14161722.
9
Inflammatory Bowel Disease and Cardiovascular Disease: An Integrative Review With a Focus on the Gut Microbiome.炎症性肠病与心血管疾病:聚焦肠道微生物群的综合综述
Cureus. 2024 Jul 22;16(7):e65136. doi: 10.7759/cureus.65136. eCollection 2024 Jul.
10
Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis.炎症性肠病中血小板参数的异常:系统评价和荟萃分析。
BMC Gastroenterol. 2024 Jul 3;24(1):214. doi: 10.1186/s12876-024-03305-9.